182
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

MicroRNA-328-3p facilitates the progression of gastric cancer via KEAP1/NRF2 axis

, , , , , & show all
Pages 595-605 | Received 03 Mar 2021, Accepted 26 Apr 2021, Published online: 23 Jun 2021

References

  • Huang L, Jansen L, Balavarca Y, et al. Decreasing resection rates for nonmetastatic gastric cancer in Europe and the United States. Clin Transl Med. 2020; 10:e203.
  • Russo AE, Strong VE. Gastric cancer etiology and management in Asia and the West. Annu Rev Med. 2019;70(1):353–367.
  • Li GM, Li L, Li MQ, et al. DAPK3 inhibits gastric cancer progression via activation of ULK1-dependent autophagy. Cell Death Differ. 2021;28(3):952–967.
  • Xu TP, Ma P, Wang WY, et al. KLF5 and MYC modulated LINC00346 contributes to gastric cancer progression through acting as a competing endogeous RNA and indicates poor outcome. Cell Death Differ. 2019;26(11):2179–2193.
  • Zhang X, Peng Y, Yuan Y, et al. Histone methyltransferase SET8 is regulated by miR-192/215 and induces oncogene-induced senescence via p53-dependent DNA damage in human gastric carcinoma cells. Cell Death Dis. 2020;11(10):937.
  • Wang S, Chen Z, Zhu S, et al. PRDX2 protects against oxidative stress induced by H. pylori and promotes resistance to cisplatin in gastric cancer. Redox Biol. 2020;28:101319.
  • Chen X, Chen X, Zhang X, et al. Curcuminoid B63 induces ROS-mediated paraptosis-like cell death by targeting TrxR1 in gastric cells. Redox Biol. 2019;21:101061.
  • Fan H, Ge Y, Ma X, et al. Long non-coding RNA CCDC144NL-AS1 sponges miR-143-3p and regulates MAP3K7 by acting as a competing endogenous RNA in gastric cancer. Cell Death Dis. 2020;11(7):521.
  • Hong D, Zhang X, Li R, et al. Deletion of TMEM268 inhibits growth of gastric cancer cells by downregulating the ITGB4 signaling pathway. Cell Death Differ. 2019;26(8):1453–1466.
  • Huang S, Li Y, Yuan X, et al. The UbL-UBA Ubiquilin4 protein functions as a tumor suppressor in gastric cancer by p53-dependent and p53-independent regulation of p21. Cell Death Differ. 2019;26(3):516–530.
  • Lovatt M, Kocaba V, Hui ND, et al. Nrf2: a unifying transcription factor in the pathogenesis of Fuchs’ endothelial corneal dystrophy. Redox Biol. 2020;37:101763.
  • Warpsinski G, Smith MJ, Srivastava S, et al. Nrf2-regulated redox signaling in brain endothelial cells adapted to physiological oxygen levels: consequences for sulforaphane mediated protection against hypoxia-reoxygenation. Redox Biol. 2020;37:101708.
  • Zhang X, Hu C, Kong CY, et al. FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT. Cell Death Differ. 2020;27(2):540–555.
  • Yamamoto M, Kensler TW, Motohashi H. The KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis. Physiol Rev. 2018;98(3):1169–1203.
  • Ma Q, He X. Molecular basis of electrophilic and oxidative defense: promises and perils of Nrf2. Pharmacol Rev. 2012;64(4):1055–1081.
  • Poh J, Ponsford AH, Boyd J, et al. A functionally defined high-density NRF2 interactome reveals new conditional regulators of ARE transactivation. Redox Biol. 2020;37:101686.
  • Gallego-Selles A, Martin-Rincon M, Martinez-Canton M, et al. Regulation of Nrf2/Keap1 signalling in human skeletal muscle during exercise to exhaustion in normoxia, severe acute hypoxia and post-exercise ischaemia: Influence of metabolite accumulation and oxygenation. Redox Biol. 2020;36:101627.
  • Hu C, Zhang X, Song P, et al. Meteorin-like protein attenuates doxorubicin-induced cardiotoxicity via activating cAMP/PKA/SIRT1 pathway. Redox Biol. 2020; 37:101747.
  • Wang CY, Zhang Q, Xun Z, et al. Increases of iASPP-Keap1 interaction mediated by syringin enhance synaptic plasticity and rescue cognitive impairments via stabilizing Nrf2 in Alzheimer’s models. Redox Biol. 2020; 36:101672.
  • Zheng H, Nong Z, Lu G. Correlation between nuclear factor E2-related factor 2 expression and gastric cancer progression. Med Sci Monit. 2015;21:2893–2899.
  • Gambardella V, Gimeno-Valiente F, Tarazona N, et al. NRF2 through RPS6 activation is related to anti-HER2 drug resistance in HER2-amplified gastric cancer. Clin Cancer Res. 2019;25(5):1639–1649.
  • Jeddi F, Soozangar N, Sadeghi MR, et al. Nrf2 overexpression is associated with P-glycoprotein upregulation in gastric cancer. Biomed Pharmacother. 2018; 97:286–292.
  • Yang Y, Tian Z, Guo R, et al. Nrf2 inhibitor, brusatol in combination with trastuzumab exerts synergistic antitumor activity in HER2-positive cancers by inhibiting Nrf2/HO-1 and HER2-AKT/ERK1/2 pathways. Oxid Med Cell Longev. 2020;2020:1–14.
  • Xu Y, Yang Y, Huang Y, et al. Inhibition of Nrf2/HO-1 signaling pathway by Dextran Sulfate suppresses angiogenesis of Gastric Cancer. J Cancer. 2021;12(4):1042–1060.
  • Hu Z, Wang X, Li D, et al. UFBP1, a key component in ufmylation, enhances drug sensitivity by promoting proteasomal degradation of oxidative stress-response transcription factor Nrf2. Oncogene. 2021;40(3):647–662.
  • Jing Y, Liang W, Liu J, et al. Autophagy-mediating microRNAs in cancer chemoresistance. Cell Biol Toxicol. 2020;36(6):517–536.
  • Smutny T, Dusek J, Hyrsova L, et al. The 3'-untranslated region contributes to the pregnane X receptor (PXR) expression down-regulation by PXR ligands and up-regulation by glucocorticoids. Acta Pharm Sin B. 2020;10(1):136–152.
  • Zhang J, Qiu WQ, Zhu H, et al. HOTAIR contributes to the carcinogenesis of gastric cancer via modulating cellular and exosomal miRNAs level. Cell Death Dis. 2020;11(9):780.
  • Yi W, Tu MJ, Liu Z, et al. Bioengineered miR-328-3p modulates GLUT1-mediated glucose uptake and metabolism to exert synergistic antiproliferative effects with chemotherapeutics. Acta Pharm Sin B. 2020;10(1):159–170.
  • Liu X, Ma R, Yi B, et al. MicroRNAs are involved in the development and progression of gastric cancer. Acta Pharmacol Sin. 2020.
  • Chen Y, Feng H, Wu Y, et al. Evaluation of plasma exosomal microRNAs as circulating biomarkers for progression and metastasis of gastric cancer. Clin Transl Med. 2020;10:e171.
  • Han TS, Hur K, Xu G, et al. MicroRNA-29c mediates initiation of gastric carcinogenesis by directly targeting ITGB1. Gut. 2015;64(2):203–214.
  • Liu Z, Sun F, Hong Y, et al. MEG2 is regulated by miR-181a-5p and functions as a tumour suppressor gene to suppress the proliferation and migration of gastric cancer cells. Mol Cancer. 2017;16(1):133.
  • Li JZ, Li J, Liu BZ. MicroRNA-328-3p inhibits malignant progression of hepatocellular carcinoma by regulating MMP-9 level. Eur Rev Med Pharmacol Sci. 2019;23(21):9331–9340.
  • Ma H, Liu T, Xu Y, et al. MiR-519d and miR-328-3p combinatorially suppress breast cancer progression. OTT. 2020;13:12987–12997.
  • Liu X, Jiang F, Wang Z, et al. Hypoxic bone marrow mesenchymal cell-extracellular vesicles containing miR-328-3p promote lung cancer progression via the NF2-mediated Hippo axis. J Cell Mol Med. 2021;25(1):96–109.
  • Wu CY, Zhou ZF, Wang B, et al. MicroRNA-328 ameliorates oxidized low-density lipoprotein-induced endothelial cells injury through targeting HMGB1 in atherosclerosis. J Cell Biochem. 2019;120(2):1643–1650.
  • Wu Z, Liu H, Sun W, et al. RNF180 mediates STAT3 activity by regulating the expression of RhoC via the proteasomal pathway in gastric cancer cells. Cell Death Dis. 2020;11(10):881.
  • Sun Y, Li S, Yu W, et al. N(6)-methyladenosine-dependent pri-miR-17-92 maturation suppresses PTEN/TMEM127 and promotes sensitivity to everolimus in gastric cancer. Cell Death Dis. 2020;11(10):836.
  • Wan X, Song Y, Fang H, et al. RANKL/RANK promotes the migration of gastric cancer cells by interacting with EGFR. Clin Transl Med. 2020; 9:3.
  • Chen F, Zhong Z, Tan HY, et al. Suppression of lncRNA MALAT1 by betulinic acid inhibits hepatocellular carcinoma progression by targeting IAPs via miR-22-3p. Clin Transl Med. 2020;10:e190.
  • Zhang X, Ma ZG, Yuan YP, et al. Rosmarinic acid attenuates cardiac fibrosis following long-term pressure overload via AMPKalpha/Smad3 signaling. Cell Death Dis. 2018;9(2):102.
  • Guo Z, Tang N, Liu FY, et al. TLR9 deficiency alleviates doxorubicin-induced cardiotoxicity via the regulation of autophagy. J Cell Mol Med. 2020;24(18):10913–10923.
  • Ma SQ, Guo Z, Liu FY, et al. 6-Gingerol protects against cardiac remodeling by inhibiting the p38 mitogen-activated protein kinase pathway. Acta Pharmacol Sin. 2021.doi:https://doi.org/10.1038/s41401-020-00587-z
  • Zhu L, Wang J, Kong W, et al. LSD1 inhibition suppresses the growth of clear cell renal cell carcinoma via upregulating P21 signaling. Acta Pharm Sin B. 2019;9(2):324–334.
  • Hu C, Zhang X, Zhang N, et al. Osteocrin attenuates inflammation, oxidative stress, apoptosis, and cardiac dysfunction in doxorubicin-induced cardiotoxicity. Clin Transl Med. 2020;10:e124.
  • Hu C, Zhang X, Wei W, et al. Matrine attenuates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via maintaining AMPKalpha/UCP2 pathway. Acta Pharm Sin B. 2019;9(4):690–701.
  • Wang M, Mao C, Ouyang L, et al. Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA. Cell Death Differ. 2019;26(11):2329–2343.
  • Tuguzbaeva G, Yue E, Chen X, et al. PEP06 polypeptide 30 is a novel cluster-dissociating agent inhibiting alpha v integrin/FAK/Src signaling in oral squamous cell carcinoma cells. Acta Pharm Sin B. 2019;9(6):1163–1173.
  • Zhang X, Hu C, Zhang N, et al. Matrine attenuates pathological cardiac fibrosis via RPS5/p38 in mice. Acta Pharmacol Sin. 2021;42(4):573–584.
  • Liu YY, Zhang S, Yu TJ, et al. Pregnancy-specific glycoprotein 9 acts as both a transcriptional target and a regulator of the canonical TGF-beta/Smad signaling to drive breast cancer progression. Clin Transl Med. 2020;10:e245.
  • Hu B, Xu Y, Li YC, et al. CD13 promotes hepatocellular carcinogenesis and sorafenib resistance by activating HDAC5-LSD1-NF-kappaB oncogenic signaling. Clin Transl Med. 2020;10:e233.
  • Zhang B, Dai Y, Zhu L, et al. Single-cell sequencing reveals novel mechanisms of Aflatoxin B1-induced hepatotoxicity in S phase-arrested L02 cells. Cell Biol Toxicol. 2020;36(6):603–608.
  • Liu R, Zhang Q, Shen L, et al. Long noncoding RNA lnc-RI regulates DNA damage repair and radiation sensitivity of CRC cells through NHEJ pathway. Cell Biol Toxicol. 2020;36(5):493–507.
  • Zhang X, Zhu JX, Ma ZG, et al. Rosmarinic acid alleviates cardiomyocyte apoptosis via cardiac fibroblast in doxorubicin-induced cardiotoxicity. Int J Biol Sci. 2019;15(3):556–567.
  • Liu FY, Fan D, Yang Z, et al. TLR9 is essential for HMGB1-mediated post-myocardial infarction tissue repair through affecting apoptosis, cardiac healing, and angiogenesis. Cell Death Dis. 2019;10(7):480.
  • Zhou YQ, Liu DQ, Chen SP, et al. Nrf2 activation ameliorates mechanical allodynia in paclitaxel-induced neuropathic pain. Acta Pharmacol Sin. 2020;41(8):1041–1048.
  • Fan D, Yang Z, Yuan Y, et al. Sesamin prevents apoptosis and inflammation after experimental myocardial infarction by JNK and NF-kappaB pathways. Food Funct. 2017;8(8):2875–2885.
  • Yang L, Zhao J, Qu Y, et al. Metoprolol prevents neuronal dendrite remodeling in a canine model of chronic obstructive sleep apnea. Acta Pharmacol Sin. 2020;41(5):620–628.
  • Zhang X, Hu C, Yuan YP, Song P, et al. Endothelial ERG alleviates cardiac fibrosis via blocking endothelin-1-dependent paracrine mechanism. Cell Biol Toxicol. 2021.doi:https://doi.org/10.1007/s10565-021-09581-5
  • Kuerban K, Gao X, Zhang H, et al. Doxorubicin-loaded bacterial outer-membrane vesicles exert enhanced anti-tumor efficacy in non-small-cell lung cancer. Acta Pharm Sin B. 2020;10(8):1534–1548.
  • Qi S, Guo L, Yan S, et al. Hypocrellin A-based photodynamic action induces apoptosis in A549 cells through ROS-mediated mitochondrial signaling pathway. Acta Pharm Sin B. 2019;9(2):279–293.
  • Pintado-Berninches L, Fernandez-Varas B, Benitez-Buelga C, et al. GSE4 peptide suppresses oxidative and telomere deficiencies in ataxia telangiectasia patient cells. Cell Death Differ. 2019;26(10):1998–2014.
  • Chen L, Chen L, Qin Z, et al. Upregulation of miR-489-3p and miR-630 inhibits oxaliplatin uptake in renal cell carcinoma by targeting OCT2. Acta Pharm Sin B. 2019;9(5):1008–1020.
  • Seo HH, Lee S, Lee CY, et al. Multipoint targeting of TGF-beta/Wnt transactivation circuit with microRNA 384-5p for cardiac fibrosis. Cell Death Differ. 2019;26(6):1107–1123.
  • Wang K, Liang Q, Li X, et al. MDGA2 is a novel tumour suppressor cooperating with DMAP1 in gastric cancer and is associated with disease outcome. Gut. 2016;65(10):1619–1631.
  • Wang J, Sun Y, Zhang X, et al. Oxidative stress activates NORAD expression by H3K27ac and promotes oxaliplatin resistance in gastric cancer by enhancing autophagy flux via targeting the miR-433-3p. Cell Death Dis. 2021;12(1):90.
  • Yuan LQ, Wang C, Lu DF, et al. Induction of apoptosis and ferroptosis by a tumor suppressing magnetic field through ROS-mediated DNA damage. Aging (Albany NY). 2020;12(4):3662–3681.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.